Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses

Virus Research

Volumn 73, Issue 1, 2001, Pages 17-26

  Roh, Sujin ^a   Lee, Yun Kyung ^b   Ahn, Byung Yoon ^c   Kiml, Kilhyoun ^a   Moon, Aree ^b  

^a Ewha Womans University   (South Korea)

^b Duksung Women's University   (South Korea)

^c Korea University   (South Korea)

Author keywords

CTL; Epitope peptide; H 2b; Hepatitis B virus; Recombinant vaccinia viruses

Indexed keywords

EPITOPE; ISOLENYLLEUCYLSERYLPROLYLPHENYLALANYLLEUCYLPROLYLLEUCYLLEUCINE; MEMBRANE ANTIGEN; PHENYLALANYLVALYLGLUTAMYLTRYPTOPHYLPHENYLALANYLVALYLGLYCYLLEUCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF;

ANIMALS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; GENETIC VECTORS; H-2 ANTIGENS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNITY, CELLULAR; MICE; MICE, INBRED C57BL; PEPTIDES; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, SYNTHETIC; VACCINIA VIRUS;

HEPATITIS B VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0035061071     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00219-7     Document Type: Article

References (23)

1. Cytotoxic T lymphocyte induced fulminant hepatitis in hepatitis B surface antigen transgenic mice. A paradigm for class I restricted immunopathology
2. Hepatitis B virus structure and biology
3. Hepatitis B virus immunopathogenesis
4. New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins
5. Cloning and expression of hepatitis B virus surface antigen gene
6. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice
7. Analysis of the stability of HLA-A2 molecules expressed on the cell surface
8. Vaccinia virus: A selective eukaryotic cloning and expression vector
9. Enhanced immunogenicity of the preS region of hepatitis B surface antigen
10. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice
11. Live recombinant vaccinia virus protects chimpanzees against hepatitis B virus
12. Antibodies to a synthetic peptide from the preS(120-145) region of the hepatitis B virus envelope are virus-neutralizing
13. The complete nucleotide sequences of the cloned hepatitis B virus DNA: Subtype adr and adw
14. MHC ligands and peptide motifs: First listing
15. Interactions between immunogenic peptides and MHC proteins
16. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: Implication for the pathogenesis of HBV-induced hepatitis
17. Immunization with soluble hepatitis B surface (S) protein particles elicits murine H-2 class I-restricted CD8 + cytotoxic T lymphocyte responses in vivo
18. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice
19. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens
20. Hepatitis B virus surface antigen particles are processed in a novel endosomal pathway for MHC class I-restricted epitope presentation
21. Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen
22. Cytotoxic T lymphocytes against soluble protein
23. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans